TSMC's Record Profit Isn't Enough — The Capex Bill Is
Taiwan Semiconductor just printed its best quarter ever — and the market is selling it. TSMC's Q2 profit surged 77% year-on-year, easily beating estimates, but the company simultaneously hiked its annual capex guidance to $60–64 billion and pledged another $100 billion for its Arizona fabs. Nasdaq 100 futures are down 1% pre-open as investors decide that this isn't a demand story — it's a spending story.
Wednesday's session closed green across the board — S&P 500 +0.38% to 7,572, Nasdaq +0.62%, Dow +0.29% — driven by Apple hitting a record high on China AI approval, Alphabet +3.6%, and a softer-than-expected PPI print that followed Tuesday's cool CPI. But the real action landed overnight: TSMC reported Q2 EPS of $4.31 versus the $3.80 consensus estimate, with net profit up 77% year-on-year to a record level, yet simultaneously raised its 2026 capex guidance from $52–56B to $60–64B and pledged an additional $100 billion for its Arizona manufacturing expansion — the market heard "spending shock" and chip stocks sold off globally, with Nasdaq 100 futures down 1% pre-open. On the other side of the ledger, UnitedHealth crushed Q2 estimates with EPS of $6.38 versus $4.85 expected and raised full-year guidance to $19.50–$20.00, sending shares up 7% premarket and putting a floor under Dow futures. The day's central tension: a semiconductor giant telling you AI demand is so strong it needs to spend more, while investors ask how much is too much.
Wednesday's Rally, Thursday's Hangover: How We Got Here
Wednesday's session was a Big Tech story wrapped in an inflation story. Apple gained 4% after reports it received approval to roll out its generative AI features in China, hitting a record high. Alphabet surged 3.6%. Microsoft rose nearly 3%. The catalyst underneath all of it: the Producer Price Index fell an unexpected 0.3% in June, extending the relief from Tuesday's CPI print, which showed annual inflation slowing to 3.5% versus the 3.8% consensus. The S&P 500 settled at 7,572.40 (+0.38%), the Nasdaq at 26,269.23 (+0.62%), and the Dow at 52,658.64 (+0.29%).
TSMC reported Q2 2026 EPS of $4.31, clearing the $3.80 Wall Street consensus by 14%, with profit up 77% year-on-year to a record level. But the company simultaneously raised its 2026 capital expenditure guidance to $60–64 billion from a prior range of $52–56 billion, and announced an additional $100 billion commitment to its Arizona fab expansion. Chip stocks globally sold off on the news: TSM ADRs fell about 4% in premarket, the VanEck Semiconductor ETF (SMH) was under pressure, and South Korea's Kospi dropped more than 5% as SK Hynix plunged 11% in Seoul.
UnitedHealth Group reported Q2 adjusted EPS of $6.38, beating the $4.85 analyst estimate by $1.53, on revenue of $112 billion that also exceeded consensus. The company raised its full-year adjusted EPS guidance to $19.50–$20.00, well above the prior outlook and the $18.48 analyst consensus. Shares jumped more than 7% in premarket trading, with UNH's weight in the Dow single-handedly keeping that index's futures in positive territory while the Nasdaq slid.
Thursday's macro slate was unambiguously solid. Initial jobless claims fell to 208,000 for the week ending July 11, down 8,000 from the prior week and well below the 218,000 Dow Jones consensus. The Philadelphia Fed's manufacturing index soared to 41.4 for July — a nearly five-year high. Retail sales rose 0.2% in line with expectations, though ex-autos sales slipped 0.2%. The labor market data, combined with soft inflation, keeps the Fed's July hold firmly in place — CME FedWatch still prices an 84.5% probability of no change at the July meeting.
A Record Beat That Sold Off: Understanding the TSMC Paradox
Here's the thing about TSMC's earnings: the headline numbers were genuinely exceptional. A 77% jump in profit, a 14% EPS beat, revenue guidance that was already known to be strong given monthly disclosure filings — none of that disappointed. But markets don't trade on whether results were good. They trade on whether results were good relative to what was already priced in, and what the forward picture looks like.
The forward picture, in this case, is a company that now expects to spend $60–64 billion in capital expenditures this year — up from a prior range of $52–56 billion — plus an additional $100 billion commitment to Arizona fabs. That's not a sign of weakness. It's actually a statement of enormous confidence in AI chip demand through 2027 and 2028. But it also compresses near-term free cash flow, raises execution risk on multiple simultaneous fab expansions across Taiwan, Japan, and the US, and revives the question that has hung over the AI trade all summer: is the infrastructure buildout getting ahead of monetizable demand?
The sell-off isn't irrational. When a company raises its spending forecast by $8–12 billion in a single quarter, investors recalibrate their free cash flow models. For equity research analysts covering the semiconductor supply chain, this print will drive revisions across the entire space — not just TSM, but Nvidia, AMD, ASML, and every memory name from SK Hynix to Micron. TSMC is the foundry underneath all of them, and its capex plan is the clearest real-world signal of where the AI infrastructure buildout is heading.
From Taiwan's Fab to Your Pre-Market Watchlist
How Today's Data Changes the Map Across Every Asset Class
Thursday's labor data — jobless claims at 208,000, Philly Fed manufacturing at 41.4 — does nothing to push the Fed off its hold. The 10-year yield edged up 3 basis points to 4.58%, a modest move. Markets are pricing an 84.5% probability of no July hike. The bond market is calm, even as the data shows an economy that isn't breaking.
The split between Dow and Nasdaq tells you exactly where money is rotating. Healthcare beats (UNH) and defensive names absorb selling from the chip trade. The AI capex story isn't over — it's entering a more demanding phase where investors want proof of monetization, not just spending. Watch whether the S&P holds above 7,500 today as a near-term support level.
Two consecutive cool inflation prints (CPI and PPI both below consensus), a labor market that continues to generate below-consensus claims, and a Philly Fed reading at a nearly five-year high: this is a Goldilocks data set. Growth is holding. Inflation is easing. The Fed has room to wait — and that's exactly what markets are pricing.
Netflix earnings after the close are the next major catalyst. Options are pricing a 7.2% implied move. Beyond that, the TSMC management conference call will be dissected for any color on AI demand duration, N2 node ramp progress, and how the $100B Arizona commitment fits into the broader US-China chip geopolitics picture.
TSMC's conference call language on AI demand sustainability and N3/N2 capacity utilization. If management signals the capex hike is demand-driven rather than speculative, the selloff could reverse quickly. If guidance for Q3 comes in soft, the chip complex could see another leg lower — taking Nvidia, AMD, and ASML with it.
Chips Down, Healthcare Up: The Sharpest Sector Split in Weeks
UnitedHealth's blowout Q2 beat — EPS $6.38 vs. $4.85 expected — and raised full-year guidance to $19.50–$20.00 sent the stock up more than 7% premarket. The medical care ratio improved to 86.7% from 89.4% a year ago, signaling genuine operational progress. As the largest private insurer in the US by revenue, UNH's recovery narrative is now being taken seriously by the market.
The chip sector is taking the brunt of TSMC's capex surprise. TSM ADRs fell ~4% premarket, Arm Holdings dropped 5%, and the VanEck SMH ETF slid ~2%. In Asia, the damage was worse: SK Hynix plunged 11% in Seoul, Samsung Electronics dropped 7%, and Japan's Advantest fell more than 6%. The sell-off is about free cash flow anxiety, not demand doubt — but the market isn't splitting hairs at the open.
Apple hit an all-time high Wednesday on China AI approval news, and Alphabet gained 3.6%. But today's chip selloff could drag on Nvidia — which relies on TSMC for its most advanced AI GPUs — and Microsoft. The question is whether Big Tech holds yesterday's gains or gives them back as the semiconductor complex reprices. Netflix earnings after the close add another variable.
What Recruiters Are Watching When They Ask About This Earnings Season
This week's earnings slate — TSMC, UnitedHealth, BlackRock, Morgan Stanley, Goldman Sachs — is a master class in how to read a beat-and-raise vs. a beat-and-selloff. Understanding the difference, and being able to explain it clearly in an interview, separates candidates who read headlines from candidates who understand markets.
A client who owns semiconductor ETFs is going to call this morning. The framework you need: TSMC's selloff is not a reflection of AI demand weakness — it's a valuation recalibration after a capex hike compressed near-term free cash flow estimates. For long-term investors, the $100B Arizona commitment is actually a signal of demand confidence. Help clients distinguish between a narrative shift and a fundamental change. This week also reinforces why diversified portfolios — with healthcare exposure alongside tech — absorb days like this more gracefully.
TSMC's capex hike is a modeling event, not just a headline. You need to revise your free cash flow assumptions for 2026 and 2027, update your capex-to-revenue ratio analysis, and re-examine what the higher spending means for gross margin guidance in H2. The secondary work: run the read-through for every name in your semiconductor coverage — Nvidia, AMD, ASML, Lam Research, Applied Materials. Each one is affected differently by TSMC building more capacity. Analysts who do this work today will have a meaningful edge on the next earnings cycle.
TSMC's $100 billion Arizona commitment is the largest single foreign corporate investment pledge in US history — an M&A and capital markets event masquerading as an earnings footnote. Think about the downstream deal activity: equipment suppliers, land and construction, local utilities, government incentive negotiations under the CHIPS Act. Any IB analyst covering technology or industrials should be thinking about how this capex cycle creates advisory and financing mandates. UnitedHealth's turnaround also signals that healthcare M&A could accelerate as the sector re-rates higher.
The Questions You Should Be Ready to Answer This Week
- "TSMC beat earnings by 14% and the stock fell. How do you explain that to a client?" — This is the core question of the day. A strong candidate explains that markets are forward-looking: the capex hike raised spending from $52–56B to $60–64B, compressing near-term free cash flow estimates. The beat was priced in; the spending surprise was not.
- What to say: "TSMC's EPS of $4.31 beat the $3.80 consensus by 14%, but the market was already expecting a strong print. What it wasn't expecting was a capex raise of $8–12 billion on top of a $100B Arizona commitment. That compresses near-term FCF and raises execution risk, which is why the stock sold off even on a record profit."
- Follow-up angle: "What does TSMC's capex tell us about the broader AI infrastructure cycle?" Answer: it signals that the company has extremely high conviction that AI chip demand will remain elevated through 2027–2028 — enough to commit to building capacity ahead of that demand curve, accepting short-term FCF pressure for long-term market share.
- Don't say: "The earnings were bad" — they weren't. The distinction between a weak result and a market expectation miss is critical in interviews. Confusing the two signals you don't understand how markets actually price stocks.
Free cash flow is the cash a company generates after accounting for capital expenditures — it's the money left over to pay dividends, buy back shares, make acquisitions, or reduce debt. FCF yield expresses that number as a percentage of the company's market cap, letting investors compare how much cash a business actually produces relative to what they're paying for it. Today's TSMC story is a perfect live example: a record-high net profit does not automatically mean record-high free cash flow if the company simultaneously announces a massive capex increase. TSMC is choosing to invest aggressively in future capacity — which reduces near-term FCF but (management is betting) will generate significantly more cash in 2027 and beyond. When a stock sells off on a big earnings beat, checking FCF guidance is almost always the right first move.
Sound Smart in Your Next Conversation
"The interesting thing about TSMC's earnings is that it's actually a bullish signal dressed up as a selloff catalyst. They raised capex from $52–56 billion to $60–64 billion because AI chip demand is strong enough to justify building that much capacity ahead of the curve. The market is reacting to the near-term free cash flow compression — but if the demand materializes, the bears on this print will look very wrong by Q1 of next year."
CNBC Markets Live Blog (July 15–16, 2026) · Yahoo Finance · Investing.com · Benzinga · Qz.com · GuruFocus · Investing.com Earnings · CME FedWatch Tool · St. Louis Fed FRED · TradingKey · The Investing Engineer · Forbes · Wikimedia Commons